rs1554810272

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_001114753.3(ENG):​c.690-1G>C variant causes a splice acceptor change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: not found (cov: 26)

Consequence

ENG
NM_001114753.3 splice_acceptor

Scores

1
3
3
Splicing: ADA: 0.9997
2

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 4.18
Variant links:
Genes affected
ENG (HGNC:3349): (endoglin) This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 6.5, offset of -28, new splice context is: gcctggcctgtccgcttcAGtgt. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-127825358-C-G is Pathogenic according to our data. Variant chr9-127825358-C-G is described in ClinVar as [Pathogenic]. Clinvar id is 1075363.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr9-127825358-C-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ENGNM_001114753.3 linkuse as main transcriptc.690-1G>C splice_acceptor_variant ENST00000373203.9 NP_001108225.1
ENGNM_000118.4 linkuse as main transcriptc.690-1G>C splice_acceptor_variant NP_000109.1
ENGNM_001278138.2 linkuse as main transcriptc.144-1G>C splice_acceptor_variant NP_001265067.1
ENGNM_001406715.1 linkuse as main transcriptc.690-1G>C splice_acceptor_variant NP_001393644.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ENGENST00000373203.9 linkuse as main transcriptc.690-1G>C splice_acceptor_variant 1 NM_001114753.3 ENSP00000362299 P2P17813-1
ENGENST00000344849.4 linkuse as main transcriptc.690-1G>C splice_acceptor_variant 1 ENSP00000341917 A2P17813-2
ENGENST00000480266.6 linkuse as main transcriptc.144-1G>C splice_acceptor_variant 2 ENSP00000479015

Frequencies

GnomAD3 genomes
Cov.:
26
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
26

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary hemorrhagic telangiectasia Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpSep 22, 2022For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 1075363). Disruption of this splice site has been observed in individuals with hereditary hemorrhagic telangiectasia (PMID: 10625079, 16525724, 22991266). This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 5 of the ENG gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ENG are known to be pathogenic (PMID: 15879500). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.58
D
BayesDel_noAF
Benign
-0.22
CADD
Pathogenic
33
DANN
Benign
0.91
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.93
D
MutationTaster
Benign
1.0
D;D;D;D
GERP RS
3.9

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.73
SpliceAI score (max)
0.96
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.62
Position offset: 27
DS_AL_spliceai
0.96
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr9-130587637; API